These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9807231)

  • 21. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for substance abuse in individuals with traumatic brain injury.
    Ashman TA; Schwartz ME; Cantor JB; Hibbard MR; Gordon WA
    Brain Inj; 2004 Feb; 18(2):191-202. PubMed ID: 14660230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST).
    Humeniuk R; Ali R; Babor TF; Farrell M; Formigoni ML; Jittiwutikarn J; de Lacerda RB; Ling W; Marsden J; Monteiro M; Nhiwatiwa S; Pal H; Poznyak V; Simon S
    Addiction; 2008 Jun; 103(6):1039-47. PubMed ID: 18373724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical validation of the National Survey on Drug Use and Health assessment of substance use disorders.
    Jordan BK; Karg RS; Batts KR; Epstein JF; Wiesen C
    Addict Behav; 2008 Jun; 33(6):782-98. PubMed ID: 18262368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using brief self-reports and clinician scales to screen for substance use disorders in psychotic patients.
    Møller T; Linaker OM
    Nord J Psychiatry; 2010 Apr; 64(2):130-5. PubMed ID: 19883188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the reliability of scores produced by the substance abuse subtle screening inventory.
    Miller CS; Woodson J; Howell RT; Shields AL
    Subst Use Misuse; 2009; 44(8):1090-100. PubMed ID: 19544146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychometric evaluation of the Substance Abuse Subtle Screening Inventory-3 with Northern Plains American Indians.
    Gray JS; Petros TV; Ayala E
    Psychol Serv; 2021 Aug; 18(3):406-415. PubMed ID: 32202847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substance dependence and level of treatment need among recently-incarcerated prisoners.
    Rounds-Bryant JL; Baker L
    Am J Drug Alcohol Abuse; 2007; 33(4):557-61. PubMed ID: 17668341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective screening of substance dependence: the advantages of directness.
    Svanum S; McGrew J
    Addict Behav; 1995; 20(2):205-13. PubMed ID: 7484314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor structure and diagnostic efficiency of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria for avoidant personality disorder in Hispanic men and women with substance use disorders.
    Becker DF; Añez LM; Paris M; Bedregal L; Grilo CM
    Compr Psychiatry; 2009; 50(5):463-70. PubMed ID: 19683617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The craving withdrawal model for alcoholism: towards the DSM-V. Improving the discriminant validity of alcohol use disorder diagnosis.
    de Bruijn C; van den Brink W; de Graaf R; Vollebergh WA
    Alcohol Alcohol; 2005; 40(4):314-22. PubMed ID: 15883129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosing major depressive disorder VI: performance of an objective test as a diagnostic criterion.
    Zimmerman M; Chelminski I; McGlinchey JB; Young D
    J Nerv Ment Dis; 2006 Aug; 194(8):565-9. PubMed ID: 16909063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development and validation of the Indigenous Risk Impact Screen (IRIS): a 13-item screening instrument for alcohol and drug and mental health risk.
    Schlesinger CM; Ober C; McCarthy MM; Watson JD; Seinen A
    Drug Alcohol Rev; 2007 Mar; 26(2):109-17. PubMed ID: 17364845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Diagnostic Inventory for Depression: a self-report scale to diagnose DSM-IV major depressive disorder.
    Zimmerman M; Sheeran T; Young D
    J Clin Psychol; 2004 Jan; 60(1):87-110. PubMed ID: 14692011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substance dependence and non-dependence in the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD): can an identical conceptualization be achieved?
    Saunders JB
    Addiction; 2006 Sep; 101 Suppl 1():48-58. PubMed ID: 16930161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders.
    Zimmerman M; Sheeran T; Chelminski I; Young D
    J Subst Abuse Treat; 2004 Apr; 26(3):181-8. PubMed ID: 15063911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying positive dissimulation by substance-abusing individuals on the Personality Assessment Inventory: a cross-validation study.
    Fals-Stewart W; Lucente S
    J Pers Assess; 1997 Apr; 68(2):455-69. PubMed ID: 9107017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychometric properties of the Substance Abuse Subtle Screening Inventory-3.
    Clements R
    J Subst Abuse Treat; 2002 Dec; 23(4):419-23. PubMed ID: 12495805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening college students for alcohol problems: psychometric assessment of the SASSI-2. Substance Abuse Subtle Screening Inventory.
    Myerholtz L; Rosenberg H
    J Stud Alcohol; 1998 Jul; 59(4):439-46. PubMed ID: 9647426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between scores on the SAAST (a direct measure of alcohol misuse) and CAL scale (an indirect measure of alcohol misuse) among medical patients admitted for treatment of alcohol dependence.
    Colligan RC; Offord KP; Morse RM; Davis LJ
    J Addict Dis; 2003; 22(3):99-110. PubMed ID: 14621348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.